Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis
Teppei Hagino, Mai Yoshida, Risa Hamada, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Effects of Tralokinumab on Clinical and Laboratory Indexes in Atopic Dermatitis: A 24-Week Real-World Study
Teppei Hagino, M Onda, Hidehisa Saeki, et al.
Dermatitis (2024)
Closed Access | Times Cited: 8
Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study
Teppei Hagino, Risa Hamada, Mai Yoshida, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 519-519
Open Access | Times Cited: 5
Predictive Factors for Poor Responders to Tralokinumab in Moderate-to-Severe Atopic Dermatitis: A Real-World Analysis
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2025)
Closed Access
Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study
Giuseppina Caiazzo, Maddalena Napolitano, Maria Quaranta, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Open Access
Predictive Factors for Long-Term High Responders to Upadacitinib Treatment in Patients with Atopic Dermatitis
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2024)
Closed Access | Times Cited: 3
Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome
Jiaoquan Chen, Shanshan Ou, Wei-Hong Wu, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 1799-1808
Open Access | Times Cited: 1
Predictive Factors for Primary and Secondary Nonresponders to Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Study
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2024)
Closed Access | Times Cited: 1
Identification of Early and Late Responders to Anti-IL-13 Antibody Tralokinumab in Atopic Dermatitis: A Real-World Japanese Study
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2024)
Closed Access | Times Cited: 1
Topical application of Artemisia annua L. essential oil ameliorates 2,4-dintrochlorobenzene-induced atopic dermatitis in mice
Zhian Huang, Bin Fan, Weiwei Mao, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118439-118439
Closed Access | Times Cited: 1
Upadacitinib - New Janus Kinase Inhibitor - Literature Review
Michalina Grzelka, Jakub Plizga, Agnieszka Głuszczyk, et al.
Quality in Sport (2024) Vol. 21, pp. 54037-54037
Open Access
Sodium Propionate Alleviates Atopic Dermatitis by Inhibiting Ferroptosis via Activation of LTBP2/FABP4 Signaling Pathway
Anni Xie, Weijia Li, Dan Ye, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 10047-10064
Open Access
Page 1

Scroll to top